No Data
No Data
Jefferies Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $170
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)
Executive Reshuffles: BA, EXPE, TPVG and GEO
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Needham Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Cuts Target Price to $195
TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $195
NoobGirl : bro is this real that roaring kitty gonna come?